Gilead’s remdesivir first to gain FDA approval for COVID-19 patients. The US Food and Drug Administration approved remdesivir (Veklury) on Thursday for treating hospitalized COVID-19 patients, a first for the disease that… Read more »
Pfizer sees data for COVID-19 vaccine’s efficacy by end of October. Amid the frantic race for a COVID-19 vaccine, Pfizer may have early efficacy results in just a matter of weeks. During a digital event Thursday,… Read more »
Pfizer to help manufacture Gilead’s remdesivir for COVID-19. Pfizer Inc. (NYC) on Friday said it inked a multiyear agreement to make COVID-19 treatment remdesivir for developer Gilead Sciences Inc. (Foster… Read more »
Slowly at first, then accelerating recently in its domestic and global footprint in drug research and regulation, China and its National Medical Products Administration (NMPA) has been on a tear…. Read more »
